2.19
price up icon1.86%   0.04
after-market Handel nachbörslich: 2.19
loading

Finanzdaten der Milestone Pharmaceuticals Inc-Aktie (MIST)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
26.30%
3.669
4.978 3.94 3.963 2.815
Operating Income/Loss
38.94%
-12.53
-20.52 -12.35 -9.616 -9.662
Income/Loss From Continuing Operations Before Tax
37.55%
-12.97
-20.76 -12.36 -9.439 -9.363
Income/Loss From Continuing Operations After Tax
37.55%
-12.97
-20.76 -12.36 -9.439 -9.363
Net Income/Loss
37.55%
-12.97
-20.76 -12.36 -9.439 -9.363
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
35.48%
-0.20
-0.31 -0.19 -0.14 -0.14
Diluted Earnings Per Share
35.48%
-0.20
-0.31 -0.19 -0.14 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.63
price down icon 0.80%
$107.39
price up icon 4.56%
$105.92
price down icon 4.21%
$98.85
price down icon 1.23%
biotechnology ONC
$320.37
price down icon 4.04%
$170.27
price down icon 3.26%
Kapitalisierung:     |  Volumen (24h):